FI102681B1 - Menetelmä glykoproteiinin valmistamiseksi - Google Patents

Menetelmä glykoproteiinin valmistamiseksi

Info

Publication number
FI102681B1
FI102681B1 FI914234A FI914234A FI102681B1 FI 102681 B1 FI102681 B1 FI 102681B1 FI 914234 A FI914234 A FI 914234A FI 914234 A FI914234 A FI 914234A FI 102681 B1 FI102681 B1 FI 102681B1
Authority
FI
Finland
Prior art keywords
glycoprotein
cells
preparation
fibroblasts
accelerating
Prior art date
Application number
FI914234A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI102681B (fi
FI914234A0 (fi
Inventor
Higashio Kanji
Mitsura Shinjiro
Shima Nobuyuki
Itagaki Yasuharu
Nagao Masaya
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26340889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI102681(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of FI914234A0 publication Critical patent/FI914234A0/fi
Application granted granted Critical
Publication of FI102681B publication Critical patent/FI102681B/fi
Publication of FI102681B1 publication Critical patent/FI102681B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
FI914234A 1989-03-10 1991-09-09 Menetelmä glykoproteiinin valmistamiseksi FI102681B1 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5863189 1989-03-10
JP669290 1990-01-16
PCT/JP1990/000314 WO1990010651A1 (fr) 1989-03-10 1990-03-09 Glycoproteine humaine, facteur physiologiquement actif la contenant, et preparation pharmaceutique le contenant en tant qu'ingredient actif

Publications (3)

Publication Number Publication Date
FI914234A0 FI914234A0 (fi) 1991-09-09
FI102681B FI102681B (fi) 1999-01-29
FI102681B1 true FI102681B1 (fi) 1999-01-29

Family

ID=26340889

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914234A FI102681B1 (fi) 1989-03-10 1991-09-09 Menetelmä glykoproteiinin valmistamiseksi

Country Status (17)

Country Link
US (2) US5587359A (hu)
EP (1) EP0462277B1 (hu)
JP (1) JPH0768272B1 (hu)
KR (1) KR960009054B1 (hu)
AT (1) ATE123498T1 (hu)
AU (1) AU629314B2 (hu)
CA (1) CA2049017C (hu)
DE (1) DE69019962T2 (hu)
DK (1) DK0462277T3 (hu)
ES (1) ES2075199T3 (hu)
FI (1) FI102681B1 (hu)
HU (2) HU212513B (hu)
IE (1) IE64005B1 (hu)
NO (1) NO180796C (hu)
NZ (1) NZ232813A (hu)
RU (1) RU2113480C1 (hu)
WO (1) WO1990010651A1 (hu)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
EP0461560B1 (en) * 1990-06-11 1998-11-18 Toshikazu Nakamura Recombinant human hepatocyte growth factor and method for production thereof
WO1992001053A1 (fr) * 1990-07-13 1992-01-23 Snow Brand Milk Products Co., Ltd. Plasmide contenant l'adn qui code pour la sequence d'acides amines du facteur tcf-ii, cellules transformees par ce plasmide et production d'une substance physiologiquement active grace a l'utilisation de ce plasmide
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
EP0571387B1 (en) * 1990-09-14 2003-12-17 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce A non-mitogenic competitive hgf antagonist
JP3200609B2 (ja) * 1990-12-28 2001-08-20 敏一 中村 上皮細胞増殖促進剤
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法
KR100271087B1 (en) * 1992-07-16 2000-11-01 Snow Brand Milk Products Co Ltd Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia
KR100260964B1 (ko) * 1992-07-16 2000-07-01 쇼노 카츄야 Tcf-ii를 유효성분으로 하는 혈액응고 정상화제
US5648233A (en) * 1992-12-28 1997-07-15 Snow Brand Milk Products Co., Ltd. Modified tumor cytotoxic factor (TCF) and DNA encoding such
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
US5837676A (en) * 1993-10-18 1998-11-17 Long Island Jewish Medical Center Use of scatter factor to enhance angiogenesis
JP2747979B2 (ja) * 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
ES2206523T3 (es) * 1994-12-27 2004-05-16 Daiichi Pharmaceutical Co., Ltd. Mutantes de tecf.
NZ298141A (en) * 1994-12-27 2000-12-22 Snow Brand Milk Products Co Ltd Treating lipid metabolism disorder using TCF-II
AU4027601A (en) * 1995-07-11 2001-07-26 Snow Brand Milk Products Co., Ltd. Lyophilized HGF preparations
JP3927248B2 (ja) * 1995-07-11 2007-06-06 第一製薬株式会社 Ｈｇｆ凍結乾燥製剤
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ZA982068B (en) * 1997-03-14 1998-09-16 Snow Brand Milk Products Co Ltd Agent for preventing and/or treating cachexia
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤
CN1352087A (zh) * 2000-11-02 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人糖蛋白42和编码这种多肽的多核苷酸
KR100562824B1 (ko) 2002-03-20 2006-03-23 주식회사 바이로메드 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
CN100417412C (zh) * 2003-03-28 2008-09-10 威海赛洛金药业有限公司 促肝细胞生长素注射液及制备方法和应用
JP4728807B2 (ja) * 2003-09-03 2011-07-20 敏一 中村 ヒト組換えｈｇｆを含有する皮膚潰瘍予防治癒剤
RU2520817C2 (ru) * 2006-01-25 2014-06-27 Октафарма Аг Очистка и применение фактора, способствующего заживлению ран
US20100124782A1 (en) * 2007-04-28 2010-05-20 Applied Cell Biotechnologies, Inc. Composition For Repairing Defect In Skin Or Gingival Soft Tissue And Method Of Culturing Autologous Fibroblasts
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
CN102046792B (zh) * 2008-04-09 2014-12-10 百疗医株式会社 用于提高质粒dna表达的冻干dna制剂
CN105682676B (zh) 2013-10-22 2020-10-23 赫利世弥斯株式会社 利用肝细胞生长因子的两种以上的异构体的肌萎缩性侧索硬化症预防或治疗用组合物
LT3138575T (lt) 2014-04-28 2021-08-25 Eisai R&D Management Co., Ltd. Liofilizuoto hgf paruošimas
DK3192524T3 (da) 2014-09-10 2022-02-14 Kringle Pharma Inc Hgf præparat egnet til behandling af neurologiske lidelser
US11548926B2 (en) 2016-03-17 2023-01-10 Eisai R&D Management Co., Ltd. Method for producing an active hepatocyte growth factor (HGF)
EP3823677A4 (en) 2018-07-19 2022-06-01 Helixmith Co., Ltd. FREEZE-DRIED PHARMACEUTICAL COMPOSITIONS INTENDED FOR NAKED-DNA GENE THERAPY
CA3218000A1 (en) 2021-05-14 2022-11-17 Claris Biotherapeutics, Inc. Compositions of growth factor for the treatment of eye disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58148826A (ja) * 1982-02-26 1983-09-05 Mochida Pharmaceut Co Ltd 糖蛋白質および腫瘍治療剤
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
DE3643182A1 (de) * 1986-12-18 1988-06-30 Behringwerke Ag Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4
JPS6410998A (en) * 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
DE3729863A1 (de) * 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
JPH0741891B2 (ja) * 1987-08-26 1995-05-10 凸版印刷株式会社 容器素材成形装置
FI80741C (fi) * 1987-10-29 1990-07-10 Laennen Tehtaat Oy Modifierat papper.
WO1992001053A1 (fr) * 1990-07-13 1992-01-23 Snow Brand Milk Products Co., Ltd. Plasmide contenant l'adn qui code pour la sequence d'acides amines du facteur tcf-ii, cellules transformees par ce plasmide et production d'une substance physiologiquement active grace a l'utilisation de ce plasmide

Also Published As

Publication number Publication date
NZ232813A (en) 1992-08-26
EP0462277A1 (en) 1991-12-27
AU5177490A (en) 1990-10-09
HU211229A9 (en) 1995-11-28
HUT58797A (en) 1992-03-30
DE69019962T2 (de) 1995-11-23
FI102681B (fi) 1999-01-29
WO1990010651A1 (fr) 1990-09-20
CA2049017C (en) 1998-10-27
KR960009054B1 (ko) 1996-07-10
DE69019962D1 (de) 1995-07-13
ATE123498T1 (de) 1995-06-15
DK0462277T3 (da) 1995-10-30
EP0462277A4 (en) 1992-08-12
IE900863L (en) 1990-09-10
NO180796B (no) 1997-03-17
US6333309B1 (en) 2001-12-25
IE64005B1 (en) 1995-06-28
NO913546D0 (no) 1991-09-09
NO913546L (no) 1991-11-11
US5587359A (en) 1996-12-24
FI914234A0 (fi) 1991-09-09
HU212513B (en) 1996-07-29
KR920701256A (ko) 1992-08-11
HU902330D0 (en) 1991-12-30
RU2113480C1 (ru) 1998-06-20
ES2075199T3 (es) 1995-10-01
EP0462277B1 (en) 1995-06-07
NO180796C (no) 1997-06-25
RU95110767A (ru) 1997-06-10
JPH0768272B1 (hu) 1995-07-26
CA2049017A1 (en) 1990-09-11
AU629314B2 (en) 1992-10-01

Similar Documents

Publication Publication Date Title
FI102681B1 (fi) Menetelmä glykoproteiinin valmistamiseksi
HU9201712D0 (en) A mammalian cytokine, il-11
CS40289A3 (en) Method of vital viral cultures maintenance
PT82736A (en) Process for preparing hybrid interferons
NZ221119A (en) Proteins with factor viii activity produced by microorganisms produced by genetic engineering
FI852522L (fi) Menetelmä tymopentiinianalogien valmistamiseksi
ZA887773B (en) Interleukin-7
DE69007744D1 (de) Verwendung von Interleukin 2 zur Behandlung von Leukämien.
DE3788796T2 (de) Serumfreies medium zur proliferation von lymphokin-aktivierten töterzellen.
EP0254369A3 (en) Branched polycarbonates containing aliphatic policarboxylic acids or derivatives thereof, and process for their preparation
IL72571A (en) Process for the maintenance and proliferation of virus genomes and derivatives thereof
DE69016693T2 (de) Züchtung von transformierten Mikroorganismen.
WO1987007640A1 (en) Process for preparing neuraminidase
IL81751A0 (en) Fermentation of bacteria at high productivities
RO92552B1 (ro) Procedeu de obtinere a unei compozitii acrilice

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ATLAS PHARMACEUTICALS INC.

Free format text: ATLAS PHARMACEUTICALS INC.